1520P Real-world assessment of NALIRIFOX for advanced pancreatic ductal adenocarcinoma: An exploratory analysis.
Saved in:
| Title: | 1520P Real-world assessment of NALIRIFOX for advanced pancreatic ductal adenocarcinoma: An exploratory analysis. |
|---|---|
| Authors: | Reichinger, A.1 (AUTHOR), Taghizadeh, H.2 (AUTHOR), Lentner, T.K.2 (AUTHOR), Reimann, P.3 (AUTHOR), Winder, T.3 (AUTHOR), Kiesl, D.4 (AUTHOR), Romeder, F.1 (AUTHOR), Webersinke, G.5 (AUTHOR), Burghofer, J.5 (AUTHOR), Kirchweger, P.6 (AUTHOR), Riedl, J.M.7 (AUTHOR), Prager, G.8 (AUTHOR), Rumpold, H.1 (AUTHOR), Doleschal, B.1 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS929-S929. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.1583 |
